<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03984240</url>
  </required_header>
  <id_info>
    <org_study_id>81701038</org_study_id>
    <nct_id>NCT03984240</nct_id>
  </id_info>
  <brief_title>The Effects of Mild Sedation on Motor Function Networks in Patients With Brian Gliomas</brief_title>
  <official_title>The Effects of Mild Sedation on Compensatory Upper Limb Motor Function Networks Based on Multimodal Magnetic Resonance Imaging in With Gliomas in Brain Eloquent Areas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Tiantan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Tiantan Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It has been shown through functional MRI (Magnetic Resonance Imaging) that patients with
      gliomas in eloquent areas have compensated neurological function by virtue of brain
      post-injury reorganization. Our previous clinical research found that mild sedation could
      induce and/or exacerbate neurological deficits, especially in limb motor and ataxia function,
      in these patients presumably by impairing functional compensation,. Nevertheless it is still
      very unclear how mild sedation affects sensorimotor networks in brains where reorganization
      may be present. Since eloquent area glioma patients are frequently subjected to sedation,
      anesthetics, and neurological examinations perioperatively, it is important to investigate
      how mild sedation interacts with motor network reorganization and functional compensation.
      Our research in patients with eloquent area gliomas will utilize neurological evaluations and
      multimodal MRI to explore the changes in brain upper limb' motor network reorganization after
      mild sedation by different sedatives-anesthetics. The neurological evaluations include
      sensorimotor function scale and testing tool. Multimodal MRI consists of 3-dimentional
      structure, blood oxygen-level dependent for cortical activation and diffusion tensor imaging
      for subcortical conduction. The data from the clinical testing and functional MRI will be
      processed and analyzed along with other relevant clinical information. This research will
      answer the question of how mild sedation affects upper limb motor function networks in brains
      with eloquent area gliomas. This new information will help optimize perioperative anesthetic
      and sedative choice for patients with eloquent area gliomas.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Brain network connectivity</measure>
    <time_frame>2 hours following sedation</time_frame>
    <description>will use fMRI and DTI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>upper limb's motor function</measure>
    <time_frame>2 hours following sedation</time_frame>
    <description>will use 9-hole peg test and motor/sensory function evaluation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pathological diagnose of glioma</measure>
    <time_frame>2 weeks after surgery completion</time_frame>
    <description>the detailed type of glioma and WHO glioma grade</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Brain Glioma</condition>
  <arm_group>
    <arm_group_label>Brain eloquent area glioma group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The brain eloquent area glioma will be diagnosed by MRI scan.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Healthy volunteers without intracranial diseases.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>Participant will be sedated by midazolam.</description>
    <arm_group_label>Brain eloquent area glioma group</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Participant will be sedated by dexmedetomidine.</description>
    <arm_group_label>Brain eloquent area glioma group</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 25 to 60 years old;

          -  Diagnosed as intracranial eloquent glioma by MRI, or healthy volunteer without any
             intracranial disease;

          -  Without history of chronic diseases;

          -  Without internal and/external metal object;

          -  Education background is beyond high school;

          -  Right handedness

        Exclusion Criteria:

          -  Unable to cooperate the neurologic function evaluation;

          -  Neuropsychiatric disorders and/or taking antipsychotic medications;

          -  Drug and/or alcohol abuse;

          -  Receiving longterm sedatives and/or analgesics;

          -  Pregnant and/or lactation period patients;

          -  Present severe cardiovascular diseases;

          -  Having claustrophobia;

          -  Body mass index equal or more than 35 kg/m2;

          -  Anticipated difficult airway;

          -  History of severe obstructive sleep apnea;

          -  History of reflux
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nan LIN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Tiantan Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nan LIN, MD, PhD</last_name>
    <phone>8610-13810108927</phone>
    <email>linnan127@gmail.com</email>
  </overall_contact>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 8, 2019</study_first_submitted>
  <study_first_submitted_qc>June 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2019</study_first_posted>
  <last_update_submitted>June 11, 2019</last_update_submitted>
  <last_update_submitted_qc>June 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Tiantan Hospital</investigator_affiliation>
    <investigator_full_name>Nan Lin</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>midazolam, dexmedetomidine, motor function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glioma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

